Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist.

Matthew Dallas Griffin

Medicine

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

Original language	English (Ireland)
Journal	J Clin Invest
Volume	116
Publication status	Published - 1 Jan 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Authors (Note for portal: view the doc link for the full list of authors)

Authors
Fife BT, Griffin MD, Abbas AK, Locksley RM, Bluestone JA

Cite this